rs3743602
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001077418.3(TMEM231):c.-6G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,416,130 control chromosomes in the GnomAD database, including 40,147 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.22 ( 3813 hom., cov: 33)
Exomes 𝑓: 0.24 ( 36334 hom. )
Consequence
TMEM231
NM_001077418.3 5_prime_UTR_premature_start_codon_gain
NM_001077418.3 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.182
Genes affected
TMEM231 (HGNC:37234): (transmembrane protein 231) This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 16-75556215-C-G is Benign according to our data. Variant chr16-75556215-C-G is described in ClinVar as [Benign]. Clinvar id is 257330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-75556215-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.248 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM231 | NM_001077418.3 | c.-6G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | ENST00000258173.11 | NP_001070886.1 | ||
TMEM231 | NM_001077418.3 | c.-6G>C | 5_prime_UTR_variant | 1/7 | ENST00000258173.11 | NP_001070886.1 | ||
TMEM231 | NM_001077416.2 | c.57G>C | p.Arg19Arg | synonymous_variant | 1/6 | NP_001070884.2 | ||
TMEM231 | NR_074083.2 | n.38G>C | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM231 | ENST00000258173.11 | c.-6G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | 1 | NM_001077418.3 | ENSP00000258173.5 | |||
TMEM231 | ENST00000568377.5 | c.-16G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/6 | 1 | ENSP00000476267.1 | ||||
TMEM231 | ENST00000565067.5 | c.-6G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/6 | 5 | ENSP00000457254.1 | ||||
TMEM231 | ENST00000258173.11 | c.-6G>C | 5_prime_UTR_variant | 1/7 | 1 | NM_001077418.3 | ENSP00000258173.5 | |||
TMEM231 | ENST00000568377.5 | c.-16G>C | 5_prime_UTR_variant | 1/6 | 1 | ENSP00000476267.1 | ||||
TMEM231 | ENST00000565067.5 | c.-6G>C | 5_prime_UTR_variant | 1/6 | 5 | ENSP00000457254.1 | ||||
TMEM231 | ENST00000562410.5 | n.-6G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.-6G>C | 5_prime_UTR_premature_start_codon_gain_variant | 1/7 | 5 | ENSP00000455520.1 | ||||
TMEM231 | ENST00000562410.5 | n.-6G>C | non_coding_transcript_exon_variant | 1/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.-6G>C | non_coding_transcript_exon_variant | 1/7 | 5 | ENSP00000455520.1 | ||||
TMEM231 | ENST00000562410.5 | n.-6G>C | 5_prime_UTR_variant | 1/7 | 1 | ENSP00000454582.1 | ||||
TMEM231 | ENST00000570006.5 | n.-6G>C | 5_prime_UTR_variant | 1/7 | 5 | ENSP00000455520.1 |
Frequencies
GnomAD3 genomes AF: 0.218 AC: 33136AN: 152088Hom.: 3808 Cov.: 33
GnomAD3 genomes
AF:
AC:
33136
AN:
152088
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.218 AC: 11887AN: 54578Hom.: 1283 AF XY: 0.221 AC XY: 6783AN XY: 30658
GnomAD3 exomes
AF:
AC:
11887
AN:
54578
Hom.:
AF XY:
AC XY:
6783
AN XY:
30658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.237 AC: 299906AN: 1263924Hom.: 36334 Cov.: 32 AF XY: 0.235 AC XY: 144285AN XY: 613532
GnomAD4 exome
AF:
AC:
299906
AN:
1263924
Hom.:
Cov.:
32
AF XY:
AC XY:
144285
AN XY:
613532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.218 AC: 33150AN: 152206Hom.: 3813 Cov.: 33 AF XY: 0.217 AC XY: 16129AN XY: 74408
GnomAD4 genome
AF:
AC:
33150
AN:
152206
Hom.:
Cov.:
33
AF XY:
AC XY:
16129
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
825
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 22, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at